Literature DB >> 15801932

Quantifying bronchodilator responses in chronic obstructive pulmonary disease trials.

Federico Lavorini1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15801932      PMCID： PMC1884812          DOI： 10.1111/j.1365-2125.2005.02400.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Effect of a previous deep inspiration on airway resistance in man.

Authors:  J A NADEL; D F TIERNEY
Journal:  J Appl Physiol       Date:  1961-07       Impact factor: 3.531

2.  A comparison of lung function methods for assessing dose-response effects of salbutamol.

Authors:  Catherine M Houghton; Ashley A Woodcock; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

3.  Measuring bronchodilation in COPD clinical trials.

Authors:  Z L Borrill; C M Houghton; A A Woodcock; J Vestbo; D Singh
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

4.  Precise diagnosis of airflow obstruction - does it matter for treatment? The assessment of reversibility: what physiological tests?

Authors:  M Demedts
Journal:  Eur Respir J       Date:  1990-10       Impact factor: 16.671

5.  Use of whole-body plethysmography to compare bronchodilator inhaler efficacy.

Authors:  A H Morice; J C Waterhouse; E M Peers; M Parry-Billings
Journal:  Respiration       Date:  1998       Impact factor: 3.580

6.  Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.

Authors:  J M Marin; S J Carrizo; M Gascon; A Sanchez; B Gallego; B R Celli
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

Review 7.  Clinical application of forced oscillation.

Authors:  M D Goldman
Journal:  Pulm Pharmacol Ther       Date:  2001       Impact factor: 3.410

Review 8.  Burden and clinical features of chronic obstructive pulmonary disease (COPD).

Authors:  Romain A Pauwels; Klaus F Rabe
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

9.  Assessment of reversibility of airflow obstruction.

Authors:  J A Van Noord; J Smeets; J Clément; K P Van de Woestijne; M Demedts
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405
  9 in total
  1 in total

1.  Psychometric validation of the Korean Patient-Reported Outcome Measurement Information System (PROMIS)-29 Profile V2.1 among patients with chronic pulmonary diseases.

Authors:  Danbee Kang; Jihyun Lim; Bo-Guen Kim; Heesu Nam; Youngha Kim; Eunjee Kang; Sooyeon Kim; Sungkeun Shim; Mangyeong Lee; Junghee Yoon; Hyun Lee; Sun Hye Shin; Hye Yun Park; Juhee Cho
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.